Coryber

$35.30
RV77

Coryber is a practitioner-only listed medicine formulated with Coptis chinensis and Corydalis turtschaninovii. It is intended for qualified healthcare practitioners seeking a traditional Chinese medicine approach to pain relief, sleep support and menstruation pain.

60 x 500 mg capsules | AUST L 171679

Each 500 mg capsule contains:

Coptis chinensis rhizome dry extract 150 mg
Equivalent to dry rhizome 2.25 g
Containing berberine 145 mg
Extract ratio 15:1

Corydalis turtschaninovii rhizome dry extract 350 mg
Equivalent to dry rhizome 1.75 g
Extract ratio 5:1

Traditionally used in Chinese medicine to:

  • relieve pain
  • induce sleep
  • relieve menstruation pain / dysmenorrhoea

Directions

Recommended practitioner dosage:

Take 1 capsule, 2 to 3 times daily, or as directed by a qualified healthcare practitioner.

Maximum daily dose: 4 capsules daily.

Dosage and duration should be determined by the treating healthcare practitioner based on individual assessment and must not exceed the ARTG-listed maximum daily dose.

Label statement

If symptoms persist, talk to your health professional.

This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level, pathway-level and traditional-use research. It does not represent additional ARTG indications for Coryber.

Coryber is relevant to practitioners interested in traditional Chinese medicine pain relief, sleep support, menstruation pain, alkaloid-rich botanical research and neuro-sensory pathway education.

The formula combines Corydalis turtschaninovii with Coptis chinensis, providing an alkaloid-rich botanical profile. Corydalis species have been discussed in professional literature in relation to traditional pain-relieving use, alkaloid constituents and pain pathway research. Recent research has examined Corydalis alkaloids and their potential mechanisms in pain-related pathways, including sensory signalling and neuroinflammatory mechanisms.

Corydalis turtschaninovii is included as the major ingredient in Coryber by quantity. Research on Corydalis turtschaninovii has investigated alkaloid profiles and analgesic activity in raw and processed preparations. This supports practitioner education around traditional pain-relieving use and botanical constituent research.

Coptis chinensis provides berberine, an isoquinoline alkaloid widely discussed in professional literature in relation to inflammatory pathways, oxidative stress, immune signalling, metabolic research and pain pathway research. This information is provided as ingredient-level education and should not be interpreted as a claim that Coryber treats metabolic disease, cardiovascular disease or inflammatory disease.

The combination of Corydalis and Coptis may be of practitioner interest where traditional Chinese medicine pain-relieving, sleep-supporting and menstruation-pain contexts are being considered. The research discussion above is provided to support professional understanding of selected ingredients, traditional use and pathway-level research.

This information is provided for practitioner education only and does not represent additional ARTG indications for Coryber.

References available to registered practitioners on request.